Generation and Characterization of Col6a1 knock-in mice: A Promising Pre-Clinical Model for Collagen VI-Related Dystrophies
Arístides López‐MárqueziD, Carmen BadosaiD, Lluis Enjuanes-Ruiz, Patricia Hernández‐Carabias, Manuel Sánchez‐MartíniD, Bruno CadotiD, Zoheir GuesmiaiD, Ioannis GeorvasilisiD, Sol BalsellsiD, Marcos Blanco-Ramos, Emma PuighermanaliD, Albert QuintanaiD, Mónica RoldániD, Valérie AllamandiD, Cecilia Jimenez-MallebreraiD
Abstract
Collagen VI Related Dystrophies (COL6-RD) are congenital muscle diseases, typically inherited as an autosomal dominant trait. A frequent type of mutation involves glycine substitutions in the triple helical domain of collagen VI alpha chains, exerting a dominant-negative effect on the unaltered protein. Despite this, no prior animal model captured this mutation type. Using CRISPR/Cas9, we generated transgenic mice with the equivalent of the human COL6A1 c.877 G>A; p. Gly293Arg mutation. We characterized their skeletal muscle phenotype over time, utilizing computer-aided tools applied to standardized parameters of muscle pathology and function. Knock-in mice exhibited early-onset reduced muscle weight, myopathic histology, increased fibrosis, reduced collagen VI expression, muscle weakness, and impaired respiratory function. These features provide adequate outcome measures to assess therapeutic interventions. The different automated image analysis methods deployed here analyze thousands of features simultaneously, enhancing accuracy in describing muscle disease models. Overall, the Col6a1 Ki Gly292Arg mouse model offers a robust platform to deepen our understanding of COL6-RD and advance its therapeutic landscape. Summary StatementWe generated and characterized over time the first mouse model representing dominant negative glycine substitutions in the alpha chains of collagen VI that are a frequent cause of Collagen VI-Related Dystrophies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 1.20
- Field percentile
- top 22%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Collagen type VI regulates TGFβ bioavailability in skeletal muscle
Payam Mohassel, Jachinta E. Rooney, … Carsten G. Bönnemann·bioRxiv·Jun 22, 2023
- Allele-specific CRISPR/Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy
Véronique Bolduc, Katherine Sizov, … Carsten G. Bönnemann·Molecular Therapy — Nucleic AcidsPeer-reviewed·Jul 16, 2024
- A missense mutation (C667F) in beta-dystroglycan results in reduced dystroglycan protein levels leading to myopathy and destabilization of the blood-brain and blood-retinal barrier protein network
R. L. Tan, F. Sciandra, … S. Blaess·bioRxiv·Nov 10, 2023
- A humanized knock-in Col6a1 mouse recapitulates a deep-intronic splice-activating variant
Véronique Bolduc, Fady Guirguis, … Carsten G. Bönnemann·bioRxiv·Mar 21, 2024
- The absence of collagen VI reduces systolic function but paradoxically increases Ca2+ release in the rat heart
Anna Maria Krstic, Hussam Moammer, … David J. Crossman·Acta PhysiologicaPeer-reviewed·Dec 22, 2025
- Generation and characterisation of mouse models of Duchenne Muscular Dystrophy (DMD)
Jayshen Arudkumar, Yu Chinn Joshua Chey, … Fatwa Adikusuma·BMC MethodsPeer-reviewed·Dec 9, 2024